Skip to Main Content

Paper Details

Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
J Pathol
50
2021
/, ARID1A, ASH1L, BRAF, CDKN2A, CDKN2A protein, DOT1L, KRAS, LGSOC, LGSOCs, Low-grade serous ovarian carcinoma, MACF1, NF2, NRAS, RAF, RAF pathway genes, RAS, TP53, USP9X, cancer, candidate genes, low-grade serous ovarian carcinoma, oestrogen, oestrogen receptor, oestrogen/, progesterone, progesterone receptor, putative novel driver genes, tumour, ubiquitin-specific protease 9X
Author NameAffiliation
Dariush EtemadmoghadamUniversity of Melbourne
Dariush EtemadmoghadamUniversity of Melbourne
Martin K??belUniversity of Calgary
Martin K??belUniversity of Calgary
David G HuntsmanUniversity of British Columbia
David G HuntsmanUniversity of British Columbia
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellPeter MacCallum Cancer Centre
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney and the Department of Gynaecological Oncology, Westmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney and the Department of Gynaecological Oncology, Westmead Hospital
Kylie L GorringeUniversity of Melbourne
Ian G CampbellPeter MacCallum Cancer Centre
Ian G CampbellUniversity of Melbourne
  • 1 - 13

Datasets

Release 1.2